| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Adial Pharmaceuticals Inc (NASDAQ: ADIL)
ADIL Technical Analysis
5
| As on 9th Jun 2023 ADIL STOCK Price closed @ 0.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.33 & Strong Sell for SHORT-TERM with Stoploss of 2.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADILSTOCK Price
| Open | 0.27 | Change | Price | % |
| High | 0.27 | 1 Day | -0.01 | -3.85 |
| Low | 0.24 | 1 Week | -0.03 | -10.71 |
| Close | 0.25 | 1 Month | -0.11 | -30.56 |
| Volume | 170840 | 1 Year | -2.38 | -90.49 |
| 52 Week High 2.85 | 52 Week Low 0.20 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ADIL Daily Charts |
ADIL Intraday Charts |
Whats New @ Bazaartrend |
ADIL Free Analysis |
|
|
ADIL Important Levels Intraday
| RESISTANCE | 0.31 |
| RESISTANCE | 0.29 |
| RESISTANCE | 0.28 |
| RESISTANCE | 0.27 |
| SUPPORT | 0.23 |
| SUPPORT | 0.22 |
| SUPPORT | 0.21 |
| SUPPORT | 0.19 |
ADIL Forecast May 2024
| 4th UP Forecast | 1.7 |
| 3rd UP Forecast | 1.23 |
| 2nd UP Forecast | 0.95 |
| 1st UP Forecast | 0.66 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.45 |
| 3rd DOWN Forecast | -0.73 |
| 4th DOWN Forecast | -1.2 |
ADIL Weekly Forecast
| 4th UP Forecast | 1.46 |
| 3rd UP Forecast | 1.07 |
| 2nd UP Forecast | 0.83 |
| 1st UP Forecast | 0.59 |
| 1st DOWN Forecast | -0.09 |
| 2nd DOWN Forecast | -0.33 |
| 3rd DOWN Forecast | -0.57 |
| 4th DOWN Forecast | -0.96 |
ADIL Forecast2024
| 4th UP Forecast | 5.74 |
| 3rd UP Forecast | 3.98 |
| 2nd UP Forecast | 2.89 |
| 1st UP Forecast | 1.8 |
| 1st DOWN Forecast | -1.3 |
| 2nd DOWN Forecast | -2.39 |
| 3rd DOWN Forecast | -3.48 |
| 4th DOWN Forecast | -5.24 |
Adial Pharmaceuticals Inc ( NASDAQ USA Symbol : ADIL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADIL Business Profile
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia. Address: 1180 Seminole Trail, Charlottesville, VA, United States, 22901
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service